• Review the most recent guidelines for breast cancer screening for women at average risk as well as higher risk.
• Identify the common risk factors for the development of breast cancer.
• Describe the most commonly used risk stratification models for breast cancer.
• Determine which women would benefit from genetic counseling for BRCA mutations.
• Discuss the use of Selective Estrogen Receptor Modulators for breast cancer prevention.

The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Alabama School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The boards of nursing in many states, including Alabama, recognize Category 1 continuing medical education courses as acceptable activities for the renewal of license to practice nursing.

Dosages, indications, and methods of use of any drug referred to in this publication may reflect the clinical experience of the authors, clinical literature, or other clinical resources. Therefore, please see the full prescribing information before using any product mentioned.

UAB is an equal opportunity/affirmative action institution.

More than 175,000 new cases of breast cancer are diagnosed each year in the United States, making it the most common diagnosed cancer behind non-melanoma skin cancer. It is the second most common cause of cancer-related death in women. The death rate has been steadily declining since 1990, likely due to early detection and improved treatment methods.

A 42-year-old woman comes to the clinic for an initial visit. She has no complaints, but is concerned about her risk of breast cancer. She has no family history of cancer and has never had any breast masses, but has not yet had her first mammogram. Her physical exam is normal except for a BMI of 35.